000 | 01058 a2200289 4500 | ||
---|---|---|---|
005 | 20250513215753.0 | ||
264 | 0 | _c20000727 | |
008 | 200007s 0 0 eng d | ||
022 | _a1080-5737 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSeidl, E C | |
245 | 0 | 0 |
_aPromising pharmacological agents in the management of acute spinal cord injury. _h[electronic resource] |
260 |
_bPharmacy practice management quarterly _cApr 2000 |
||
300 |
_a21-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 |
_aAntioxidants _xadverse effects |
650 | 0 | 4 |
_aG(M1) Ganglioside _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMethylprednisolone _xadverse effects |
650 | 0 | 4 |
_aNaloxone _xadverse effects |
650 | 0 | 4 |
_aNarcotic Antagonists _xadverse effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xadverse effects |
650 | 0 | 4 |
_aPregnatrienes _xadverse effects |
650 | 0 | 4 |
_aSpinal Cord Injuries _xdrug therapy |
773 | 0 |
_tPharmacy practice management quarterly _gvol. 20 _gno. 1 _gp. 21-7 |
|
999 |
_c10896250 _d10896250 |